Sarah Gheuens

Chief Medical Officer

Sarah Gheuens (Chief Medical Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Agios Pharmaceuticals, Inc. (AGIO). The largest single filing was $914K of AGIO (30,000 sh × $30.48, as filed), executed Aug 4.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.4M

shares × price, as filed

Last traded

Aug 4

Filed Aug 6

Median ADV $39.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

AGIO

Agios Pharmaceuticals, Inc. AGIO · 0 buys · 7 sells 7 filings

Recent filings

AGIOSALE Agios Pharmaceuticals, Inc. View filing → $914K
30,000 sh × $30.48
Exec Aug 4
Filed Aug 6 · 4:13 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $151K
4,007 sh × $37.56
Exec Jul 1
Filed Jul 2 · 4:03 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $102K
2,940 sh × $34.71
Exec Apr 2
Filed Apr 6 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $107K
2,454 sh × $43.78
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $145K
3,302 sh × $43.92
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $420K
11,067 sh × $37.93
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET AGIOSALE Agios Pharmaceuticals, Inc. View filing → $140K
4,091 sh × $34.17
Exec Jul 1 2025
Filed Jul 3 2025 · 5:30 PM ET